Effective apatinib treatment of pleomorphic liposarcoma: A case report

    loading  Checking for direct PDF access through Ovid


Rationale:Pleomorphic liposarcoma (PLS) is a rare and aggressive malignant tumor, and both radiation and conventional cytotoxic chemotherapy remain controversial for metastatic or unresectable disease.Patient Concerns:We presented an 81-year-old Chinese woman with advanced PLS who received apatinib after failure chemotherapy.Diagnoses:The patient was diagnosed as having PLS by biopsy.Interventions: After a failed chemotherapy, apatinib started to be taken orally 425 mg per day.Outcomes:This patient achieved 3-month progression-free survival (PFS) and a higher quality of life. Meanwhile, this patient suffered grade 2 hypertension and grade 3 hand–foot syndrome (HFS).Lessons: In this case, apatinib presented good efficacy and safety to treat PLS. Randomized clinical studies are required to confirm the efficacy and safety of apatinib in the treatment of PLS.

    loading  Loading Related Articles